Concourse Financial Group Securities, Inc. Trans Medics Group, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
SELL
$135.68 - $176.11 $40,704 - $52,833
-300 Closed
0 $0
Q2 2024

Jul 23, 2024
BUY
$72.62 - $150.62 $21,786 - $45,186
300 New
300 $45,000
Q1 2024

Apr 30, 2024
BUY
$70.86 - $89.93 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024
BUY
$36.74 - $81.08 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$53.47 - $96.07 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$53.47 - $96.07 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$66.23 - $88.73 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$53.63 - $82.33 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$39.08 - $64.29 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$31.56 - $55.75 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$20.56 - $32.15 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$12.58 - $26.94 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$19.16 - $32.68 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$25.92 - $34.51 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$21.63 - $40.07 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$17.75 - $47.82 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$11.91 - $19.9 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$13.78 - $18.84 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$11.66 - $18.26 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020
BUY
$10.5 - $20.2 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020
BUY
$16.61 - $21.64 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$20.27 - $28.93 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$22.36 - $30.41 $0 - $0
0 New
0 $0

Others Institutions Holding TMDX

# of Institutions
396
Shares Held
31.9M
Call Options Held
466K
Put Options Held
286K
View Full List

About TransMedics Group, Inc.

TMDX Quotes by TradingView
  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.53B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email